热线电话: 021-34661275
产品分类/PRODUCT CLASSIFICATION

上海细胞库

人源细胞系| 稳转细胞系| 基因敲除株| 基因点突变细胞株| 基因过表达细胞株| 重组细胞系| 猪的细胞系| 马细胞系| 兔的细胞系| 犬的细胞系| 山羊的细胞系| 鱼的细胞系| 猴的细胞系| 仓鼠的细胞系| 狗的细胞系| 牛的细胞| 大鼠细胞系| 小鼠细胞系| 其他细胞系|

原代细胞

原代细胞| 永生化细胞|

细胞培养

血清| 无血清冻存| 细胞培养试剂盒| 普通培养基| 完全培养基| 细胞污染预防| 细胞污染清除| 细胞培养辅助试剂|

细胞服务

STR鉴定服务| ATCC代购服务|

酶联试剂盒

人ELISA试剂盒| 大鼠ELISA试剂盒| 小鼠ELISA试剂盒| 兔ELISA试剂盒| 猪ELISA试剂盒| 鱼ELISA试剂盒| 牛ELISA试剂盒| 犬ELISA试剂盒| 鸭ELISA试剂盒| 豚鼠ELISA试剂盒| 鸡ELISA试剂盒| 绵羊ELISA试剂盒| 山羊ELISA试剂盒| 仓鼠ELISA试剂盒| 植物ELISA试剂盒| 药残留类试剂盒| 其他ELISA试剂盒|

生化试剂盒

生化试剂盒| 微量法检测盒| 分光法检测盒| 胶体金检测盒|

PCR试剂盒

荧光探针PCR试剂盒| 染料荧光PCR试剂盒| 核酸扩增/纯化| 普通PCR检测试剂盒| 质粒菌种感受态|

抗体蛋白

蛋白多肽| 抗体| 免疫组化| 免疫球蛋白|

试剂耗材

标准试液| 科研试剂| 缓 冲 液| 实验耗材| 高效液相色谱对照品|

首页 > 抗体蛋白 > 抗体
Purified anti-human CD19 Antibody
产品名称：
Purified anti-human CD19 Antibody
产品类别：
抗体
产品编号：
302201
产品应用：
302201
[价格]
规格 价格 库存
25µg ￥ 420 1

产品详情

Product Details

Verified Reactivity
Human
Reported Reactivity
Chimpanzee
Antibody Type
Monoclonal
Host Species
Mouse
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C.
Application

FC - Quality tested
CyTOF?,?IHC-F - Verified
PG - Reported in the literature, not verified in house
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.5 ?g per 106 cells in 100 ?l volume or 100 ?l of whole blood. For immunohistochemistry, a concentration range of 5.0 - 10 ?g/ml is suggested. It is recommended that the reagent be titrated for optimal performance for each application.

Application Notes

Additional reported applications (for the relevant formats) include: immunohistochemical staining of acetone-fixed frozen tissue sections8 and blocking of B cell proliferation. Clone HIB19 is not recommended for formalin-fixed paraffin-embedded sections. The Ultra-LEAF? purified antibody (Endotoxin < 0.01 EU/?g, Azide-Free, 0.2 ?m filtered) is recommended for functional assays (Cat. No. 302267 & 302268).

?

Clone HIB19 partially blocks anti-human CD19 clones 4G7 and SJ25C1 staining based on in-house testing

Application References

(PubMed link indicates BioLegend citation)
  1. Schlossman S, et al. 1995. Leucocyte Typing V. Oxford University Press. New York.
  2. Knapp W, et al. 1989. Leucocyte Typing IV. Oxford University Press. New York.
  3. Bradbury L, et al. 1993. J. Immunol. 151:2915.
  4. Joseph A, et al. 2010. J. Virol. 84:6645. PubMed
  5. Wang X, et al. 2010. Haematologica. 95:884. (FC) PubMed
  6. Walker JD, et al. 2009. J. Immunol. 182:1548. (Block) PubMed
  7. Yoshino N, et al. 2000. Exp. Anim. (Tokyo) 49:97. (FC)
  8. Hansen A, et al. 2002. Arthritis Rheum. 46:2160. (IHC)
  9. Stoeckius M, et al. 2017. Nat. Methods. 14:865. (PG)
  10. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
Product Citations
  1. Fu J et al. 2019. Cell stem cell. 24(2):227-239 . PubMed
  2. Dallari S, et al. 2017. Nat Commun. 8:14830. PubMed
  3. Rouers A, et al. 2021. Cell Rep Med. 2:100278. PubMed
  4. Weinhage T, et al. 2020. J Immunol. 205:56. PubMed
  5. Gadalla R, et al. 2022. STAR Protoc. 3:101643. PubMed
  6. Alroqi F, et al. 2017. J Clin Immunol. . 10.1007/s10875-017-0451-1. PubMed
  7. Walker J, et al. 2009. J Immunol. 182:1548. PubMed
  8. Korn MA, et al. 2020. J Immunol. 205:2595. PubMed
  9. Cao Q, et al. 2018. Am J Physiol Renal Physiol. 314:F561. PubMed
  10. Gupta R, et al. 2022. Front Immunol. 13:886442. PubMed
  11. Pugh J, et al. 2021. PeerJ. 9:e12258. PubMed
  12. Chakhtoura M, et al. 2021. PLoS Pathog. 17:e1009732. PubMed
  13. Lartey S, et al. 2020. J Infect Dis. 221:21. PubMed
  14. Winkler M, et al. 2017. PLoS One.. 10.1371/journal.pone.0182427. PubMed
  15. Mann ER, et al. 2020. Sci Immunol. :5. PubMed
  16. Kaufmann M, et al. 2021. Med. 2(3):296-312.e8. PubMed
  17. Sigal N, et al. 2022. Methods Mol Biol. 2543:113. PubMed
  18. Zhang Y, et al. 2022. Exp Hematol Oncol. 11:15. PubMed
  19. Gruber CN, et al. 2020. Immunity. 53(3):672-684. PubMed
  20. Li Y, et al. 2019. Front Immunol. 0.460416667. PubMed
  21. Yoshihara S, et al. 2019. Front Immunol. 0.545833333. PubMed
  22. Smillie CS et al. 2019. Cell. 178(3):714-730 . PubMed
  23. Liu X, et al. 2022. STAR Protoc. 3:101310. PubMed
  24. Sun Y, et al. 2022. Nat Commun. 13:3916. PubMed
  25. Ferdosi SR, et al. 2019. Nat Commun. 1.695833333. PubMed
  26. Martin JC, et al. 2020. Cell. 178(6):1493-1508.e20.. PubMed
  27. Cerignoli F, et al. 2018. PLoS One. 13:e0193498. PubMed
  28. O'Boyle KC, et al. 2020. Methods Mol Biol. 2111:1. PubMed
  29. Eldredge LC, et al. 2019. Am J Physiol Lung Cell Mol Physiol. 317:L49. PubMed
  30. Johnston HE, et al. 2018. Mol Cell Proteomics. 1.247222222. PubMed
  31. Bruno TC, et al. 2017. Cancer Immunol Res. 0.831944444. PubMed
  32. Corleis B, et al. 2017. PLoS One. 12:e0173161. PubMed
  33. Speir M,et al. 2017. Sci Rep.. 10.1038/s41598-017-14690-5. PubMed
  34. Agrawal N, et al. 2018. Front Immunol. 2.053472222. PubMed
  35. Baskar R, et al. 2022. Cell Rep Methods. 2:. PubMed
  36. Renand A, et al. 2018. J Allergy Clin Immunol. 141:1750. PubMed
  37. Del Alcazar D, et al. 2019. Cell Rep. 28:3047. PubMed
  38. Sattler A, et al. 2021. Am J Transplant. 21:87. PubMed
  39. Han L, et al. 2019. Haematologica. 10.3324/haematol.2018.205534. PubMed
  40. Chng MHY, et al. 2020. Immunity. 51(6):1119-1135.e5.. PubMed
  41. Singh AK, et al. 2017. Front Immunol. 0.513888889. PubMed
  42. Han SS, et al. 2018. Oncotarget. 9:3292. PubMed
  43. Roussel M, et al. 2021. Cell Reports Medicine. 2(6):100291. PubMed
  44. Lee YS, et al. 2021. J Immunother Cancer. 9:. PubMed
  45. Kato M, et al. 2021. PLoS One. 16:e0252116. PubMed
  46. Newell KL, et al. 2021. PLoS One. 16:e0244855. PubMed
  47. Bengsch B et al. 2018. Immunity. 48(5):1029-1045 . PubMed
  48. Evrard M et al. 2018. Immunity. 48(2):364-379 . PubMed
  49. Schwabenland M, et al. 2021. Immunity. . PubMed
  50. De Maeyer RPH, et al. 2020. Nat Immunol. 21:615. PubMed
  51. Anna F, et al. 2021. J Immunother Cancer. 9:. PubMed
  52. Crome SQ, et al. 2017. Nat Med. 1.213888889. PubMed
  53. Afzali B, et al. 2017. Nat Immunol. 18:813. PubMed
  54. Kennedy-Darling J, et al. 2021. Eur J Immunol. 51:1262. PubMed
  55. Vanshylla K, et al. 2018. Eur J Immunol. 48:441. PubMed
  56. Dinh HQ, et al. 2020. Immunity. 53(2):319-334.e6. PubMed
  57. Crawford LB, et al. 2021. J Virol. 95:. PubMed
  58. Ainai A, et al. 2020. Microbiol Immunol. 64:313. PubMed
  59. Leylek R, et al. 2020. Cell Rep. 32:108180. PubMed
  60. Lavin Y et al. 2017. Cell. 169(4):750-765 . PubMed
  61. Martin E, et al. 2020. JCI Insight. :5. PubMed
  62. Chiou SH, et al. 2021. Immunity. 54:586. PubMed
RRID
AB_314231 (BioLegend Cat. No. 302201) AB_314232 (BioLegend Cat. No. 302202)

Antigen Details

Structure
Ig superfamily, type I transmembrane glycoprotein, 95 kD
Distribution

B lineage (except plasma cells), follicular dendritic cells

Function
B cell activation and differentiation
Ligand/Receptor
Forms complex with CD21 (CR2) and CD81 (TAPA-1), BCR coreceptor
Cell Type
B cells, Dendritic cells
Biology Area
Costimulatory Molecules, Immunology
Molecular Family
CD Molecules
Antigen References

1. Tedder T, et al. 1994. Immunol. Today 15:437.
2. Bradbury L, et al. 1993. J. Immunol. 151:2915.

Gene ID
930 View all products for this Gene ID
UniProt
View information about CD19 on UniProt.org

联系我们

TEL：021-34661275 　点击拨打热线